Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 276

    1.

    Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.

    Hadigan C, Yawetz S, Thomas A, Havers F, Sax PE, Grinspoon S.

    Ann Intern Med. 2004 May 18;140(10):786-94.PMID: 15148065 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Rosiglitazone treatment for fat redistribution and metabolic abnormalities caused by anti-HIV therapy.

    [No authors listed]

    Ann Intern Med. 2004 May 18;140(10):I36. No abstract available. PMID: 15148089 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.

    van Wijk JP, de Koning EJ, Cabezas MC, op't Roodt J, Joven J, Rabelink TJ, Hoepelman AI.

    Ann Intern Med. 2005 Sep 6;143(5):337-46. Erratum in: Ann Intern Med. 2005 Nov 1;143(9):695. Dosage error in published abstract; MEDLINE/PubMed abstract corrected. PMID: 16144892 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.

    Sutinen J, Häkkinen AM, Westerbacka J, Seppälä-Lindroos A, Vehkavaara S, Halavaara J, Järvinen A, Ristola M, Yki-Järvinen H.

    Antivir Ther. 2003 Jun;8(3):199-207.PMID: 12924536 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.

    Sutinen J, Kannisto K, Korsheninnikova E, Fisher RM, Ehrenborg E, Nyman T, Virkamäki A, Funahashi T, Matsuzawa Y, Vidal H, Hamsten A, Yki-Järvinen H.

    Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E941-9. Epub 2004 Jan 28.PMID: 14749206 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients.

    Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y, Wang JP, Chen CL, Tai TY, Chuang LM.

    Diabetes Care. 2002 Feb;25(2):376-80.PMID: 11815513 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

    Carr A, Workman C, Carey D, Rogers G, Martin A, Baker D, Wand H, Law M, Samaras K, Emery S, Cooper DA; Rosey investigators.

    Lancet. 2004 Feb 7;363(9407):429-38.PMID: 14962523 [PubMed - indexed for MEDLINE]Related articles

    8.

    Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy.

    Kovacic JC, Martin A, Carey D, Wand H, Mallon PW, Feneley MP, Emery S, Cooper DA, Carr A; ROSEY Investigators.

    Antivir Ther. 2005;10(1):135-43.PMID: 15751771 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

    Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W.

    Antivir Ther. 2008;13(1):67-76.PMID: 18389900 [PubMed - indexed for MEDLINE]Related articles

    10.

    Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.

    Hadigan C, Liebau J, Torriani M, Andersen R, Grinspoon S.

    J Clin Endocrinol Metab. 2006 Nov;91(11):4438-44. Epub 2006 Aug 29.PMID: 16940448 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.

    Koutkia P, Canavan B, Breu J, Torriani M, Kissko J, Grinspoon S.

    JAMA. 2004 Jul 14;292(2):210-8.PMID: 15249570 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

    Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S.

    J Infect Dis. 2007 Jun 15;195(12):1754-61. Epub 2007 May 2.PMID: 17492590 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).

    Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Römer V, Haider D, Pacini G, Ludvik B.

    Horm Metab Res. 2009 Jul;41(7):573-9. Epub 2009 Mar 25.PMID: 19322744 [PubMed - indexed for MEDLINE]Related articles

    14.

    Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial.

    Hadigan C, Corcoran C, Basgoz N, Davis B, Sax P, Grinspoon S.

    JAMA. 2000 Jul 26;284(4):472-7.PMID: 10904511 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.

    Mulligan K, Yang Y, Wininger DA, Koletar SL, Parker RA, Alston-Smith BL, Schouten JT, Fielding RA, Basar MT, Grinspoon S.

    AIDS. 2007 Jan 2;21(1):47-57.PMID: 17148967 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.PMID: 15356026 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Adipocyte-derived hormone levels in HIV lipodystrophy.

    Kosmiski L, Kuritzkes D, Lichtenstein K, Eckel R.

    Antivir Ther. 2003 Feb;8(1):9-15.PMID: 12713059 [PubMed - indexed for MEDLINE]Related articles

    19.

    Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.

    Lo J, You SM, Canavan B, Liebau J, Beltrani G, Koutkia P, Hemphill L, Lee H, Grinspoon S.

    JAMA. 2008 Aug 6;300(5):509-19.PMID: 18677023 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone.

    Kamin D, Hadigan C, Lehrke M, Mazza S, Lazar MA, Grinspoon S.

    J Clin Endocrinol Metab. 2005 Jun;90(6):3423-6. Epub 2005 Mar 1.PMID: 15741250 [PubMed - indexed for MEDLINE]Related articlesFree article